Neumora Therapeutics IPO Presentation Deck
Neumora's Precision Medicine Approach Can Be Leveraged to Maximize the Value of
Our Programs
Challenge: Match Right
Drug to the Right Patient
●
●
●
How do we gain further
confidence in a selected target?
How do we identify indications for
a given target?
How do we identify likely
responders / treatment non-
responders?
Neumora's
Precision Toolbox
Proprietary analytical capabilities with
one petabyte of data onboarded
Molecular, Translational,
and Clinical Tools
(e.g., genomics, proteomics, EEG,
Imaging, Digital, Clinical measures)
Multimodal Methods
(e.g., Al/ML, analytic capabilities)
Longitudinal, Multi-modal
patient datasets (MDD,
schizophrenia, anxiety, ALS, PD, AD)
Maximize Value: Improve
Probability of Success &
Expand Indications
●
Gain confidence in target and/or
indication
• Characterize more homogeneous,
targeted patient populations
Inform inclusion / exclusion criteria
Increase indication expansion
opportunities
●
• Identify placebo responders
• Identify biomarkers
●
Neumora applies precision medicine approaches to our programs on an as
needed basis in a fit for purpose manner
Confidential
26View entire presentation